Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Inspirna, Inc.

News headline image
Inspirna Announces Appointment of Karim Benhadji, M.D., as Chief Medical Officer and Retirement of Robert Wasserman, M.D.
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna Partners with Merck KGaA, Darmstadt, Germany, to Accelerate Global Development of Ompenaclid (RGX-202)
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna Announces Clinical Data from Phase 1b/2 Study of Ompenaclid (RGX-202) in Advanced Colorectal Cancer at ESMO Congress 2023
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna to Present Clinical Data from Phase 1b/2 Study of Ompenaclid (RGX-202) in Advanced Colorectal Cancer at ESMO Congress 2023
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna to Present at the Jefferies Healthcare Conference
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna Appoints Dr. Usman “Oz” Azam, M.D., as New Chief Executive Officer
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna Announces Interim Data from Phase 1b/2 Study of Abequolixron (RGX-104) in Relapsed or Refractory Lung Cancer
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna to Present at the Evercore ISI Annual HealthCONx Conference
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna Raises $50 Million in Series D Financing
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna to Present Phase 1b RGX-202-01 Clinical Trial Data at the 2022 ESMO World Congress on Gastrointestinal Cancer
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna to Present Phase 1b RGX-202-01 Clinical Trial Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna Announces Phase 1b RGX-202 Clinical Trial Data Selected for Poster Presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna to Present at 21st Annual Needham Virtual Healthcare Conference
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna Strengthens Scientific Advisory Board with Two Globally Renowned Experts in Gastrointestinal Oncology
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna to Present at the Stifel 2021 Virtual Healthcare Conference
From Inspirna, Inc.
Via Business Wire
News headline image
Inspirna Announces Clinical Collaboration with Bristol Myers Squibb to Study RGX-104 in Combination with Yervoy® (ipilimumab) for Treatment of Metastatic Endometrial Cancer
From Inspirna, Inc.
Via Business Wire
News headline image
RGENIX Announces Company Name Change to Inspirna and Expands Board of Directors with Appointment of Pharma Veteran Dieter Weinand
From Inspirna, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.